Breast Cancer
Breast Cancer
Advertisement
Rob DillardOncology | February 26, 2024
A study found a "substantial deficit" of undiagnosed cancer cases during the COVID-19 pandemic.
Read More
Rob DillardBreast Cancer | February 12, 2024
Completing HBOT appears effective at reducing pain and fibrosis in patients with irradiated breast cancer.
Rob DillardBreast Cancer | February 1, 2024
A researcher is looking to prove that nebivolol, an FDA-approved drug for high blood pressure, is effective at treating TNBC.
Rob DillardBreast Cancer | January 22, 2024
Screening and new treatments have led to a US breast cancer mortality rate that is 58% lower than in it was in the mid-1970s.
Ashley GainesBreast Cancer | January 18, 2024
The FDA recently approved a new combination therapy for the treatment of HR-positive, HER2-negative breast cancer.
Rob DillardBreast Cancer | January 9, 2024
CNS radiotherapy with pyrotinib and capecitabine improves CNS progression in breast cancer patients with brain metastases.
Oncology BrothersOncology Brothers | December 21, 2023
The Oncology Brothers talk with Paolo Tarantino, MD, about the TROPiCS-02 study presented at SABCS.
Rebecca AraujoBreast Cancer | November 16, 2023
For patients with breast cancer, a regimen of epirubicin followed by adjuvant chemotherapy is associated with worse QOL.
Rob DillardBreast Cancer | October 31, 2023
Drs. Vishwas Paralkar and Sophia Gayle discuss CBX-15, a novel therapy for triple-negative breast cancer.
Rob DillardBreast Cancer | October 10, 2023
Dan Forche, CEO of PreludeDx, a leader in precision medicine for early-stage breast cancer, discusses DCISionRT.
The Fellow on CallThe Fellow on Call | August 24, 2023
Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey.
The Fellow on CallThe Fellow on Call | July 31, 2023
The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types.
The Fellow on CallThe Fellow on Call | July 31, 2023
The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+.
The Fellow on CallThe Fellow on Call | July 13, 2023
The Fellow on Call Podcast shifts its breast cancer focus to the triple-negative subtype.
The Fellow on CallThe Fellow on Call | July 7, 2023
The Fellow on Call Podcast shifts their focus from ER+ to HER+ breast cancer, detailing treatment options, and much more.
The Fellow on CallThe Fellow on Call | July 31, 2023
The Fellow on Call group continues discussing the management of early stage ER+/HER2-breast cancer.
Patrick DalyASCO 2023 | June 15, 2023
Real-world outcomes were comparable to clinical trials in breast cancers with BRCA mutations treated with PARP inhibitors.
Patrick DalyASCO 2023 | June 15, 2023
A cohort analysis found abbreviated breast MRI was an effective for cancer screening in patients with dense breasts.
Patrick DalyASCO 2023 | June 15, 2023
Patients with DCIS breast cancer had "excellent disease control" after lumpectomy and accelerated partial breast irradiation.
Advertisement
Advertisement
Advertisement
Latest News

February 27, 2024